Objectives: To reduce treatment planning times while maintaining plan quality through the introduction of semi-automated planning techniques for breast radiotherapy.
2 | ME TH ODS
2.A | Patient/plan data
The treatment plans for 40 clinical breast radiotherapy patients were selected consecutively from a reverse chronologically ordered list. All patients had consented at time of treatment for their images to be used for research purposes. Patients had previously been scanned using either a Philips Brilliance Big Bore (60-cm field of view, 2-mm slice thickness) or GE Lightspeed (50-cm field of view, 1.25-mm slice thickness) CT scanner. Outlining and planning were carried out on a Pinnacle 3 v9.8 treatment planning system.
Scripting was performed using the planning system's inbuilt programming language, which incorporates object-oriented aspects. All patients were treated to a prescription dose of 40 Gy in 15 fractions with field energies of predominantly 6 MV; 10 MV was also used when necessary for patients with large chest wall separation.
The median (range) of breast volumes treated was 952 cc (223-2697 cc). Of these, 18 were left-sided treatments and 22 were right-sided. Eight patients received irradiation to the supraclavicular fossa.
2.B | SPICE
The autosegmentation software used was the Smart Probabilistic
Image Contouring Engine (SPICE), a purchasable module for Pinnacle 3 . 14 The autosegmentation process applies rigid and deformable registrations together with probability-based structure refinements.
The modified atlas contours are subsequently added to the structure set. The suitability of the SPICE heart and lungs volumes for clinical use was investigated using a cohort of ten patients from the UK HeartSpare study. 15 The volumes created were compared quantitatively to those defined by an experienced radiation oncologist using the Dice Similarity Coefficient (DSC), which is twice the ratio of the volume of the overlapping region to the sum of the two volumes. A comparison between mean heart doses was also performed. 14 
2.C | Scripting
A script was developed (PW, RAM) with the aim of automating parts of the breast planning process in order to facilitate reductions in step-and-shoot planning times while maintaining plan quality. The script workflow is given in (Fig. 1) ; it was not the purpose of this script to automate tangential field placement. The first part of the script initially created the prescription point at the isocenter of the breast fields and set a default prescription of 40 Gy in 15 fractions; the beam weightings were also set for each beam to give equal contributions to the dose at the prescription point. The planner had then to derive the necessary minimum, uncompensated, dose coverage of the whole breast by renormalizing the open tangential field distribution to achieve 95% dose coverage.
The second part of the script detected the plan maximum dose and created a set of prespecified isodose volumes from 105% of the prescription dose up to approximately the maximum dose. The purpose of this was to introduce control points with Multileaf Collimator (MLC) shielding for dose distribution homogenization. For control point MLC leaves to conform to the isodose volumes, the script was required to first expand the isodose volumes beyond the anterior field edges. By utilizing the expanded isodose volumes as block structures within the treatment planning system's block creation tool, the script added control points with the MLC leaf positions required to homogenize dose at the specified isodose levels. Approximately the same number of control points were added for each field. To achieve good conformation, the isodose volume expansion direction was defined to be approximately parallel to the direction of MLC leaf travel. This was scripted by introducing gantry and collimator angle dependences into the expansion definitions; expansion magnitudes and directions were defined explicitly for set collimator and gantry angle ranges. The result was a step-wise expansion of the isodose volumes, which consisted of several large anterior expansions coupled with smaller superior/inferior expansions/contractions.
Cardiac and lung MLC shielding were defined by the local Virtual Simulation clinical protocol implementation process. The Pinnacle 3 block tool removed this from the shielding control points.
The script restored the cardiac and lung shielding using the first control point on each field, which was an unmodified open-field segment, identifying the posterior leaf bank using treatment field gantry and collimator angles, and then extracting the corresponding MLC leaf positions. These were applied to the remaining control points. From (Fig. 1) , this was performed during the segment creation process. The script's functionality was not affected by the presence of additional fields, for example, to treat nodes in the supraclavicular fossa.
Control point Monitor Units (MU) were then derived using segment weight optimization. Pinnacle 3 utilizes a gradient descent method during optimization; this particular technique optimizes the MU per segment in order to satisfy the dosimetric objectives. 16 The optimization objectives added by the second part of the script were: 
2.D | Planning
All planning was conducted by a single planner. The SPICE module was applied and plans were then created retrospectively using the scripts. All patients were further retrospectively planned manually and planning times were measured using a stopwatch. Dose calculations were performed using a collapsed cone convolution algorithm on a 0.25 9 0.25 9 0.25 cm 3 resolution dose grid. Plan statistics were extracted using the whole breast, field-based definition as per the IMPORT HIGH trial for the original and scripted plans. 17 The whole breast volume was created from the 50% dose level, contracted by 10 mm superior/inferior and 5 mm posterior. This volume excludes the lungs expanded by 5 mm and the skin, which is taken to be 5 mm from the external contour. Dose homogeneity was quantified by the homogeneity index, defined as the ratio of the difference between the breast D 2% and D 98% to the D 50% . 18 Tests for normality were undertaken by histogram and Q-Q plot inspection and the Wilcoxon Signed Rank Test was used to identify statistically significant differences between plan types. 
| RESULTS

3.A | SPICE
A summary of the comparison between the heart and lungs volumes created by the clinician and those added by the SPICE thorax atlas is given in (Table 1) . SPICE creates two heart volumes (Heart 1 and
Heart 2); according to Bzdusek et al., this was found to be necessary during the acquisition of the ground truth patient data that constitute the atlas. 14 More superior slices were outlined by the Heart 1 structure; however, the remaining slices corresponded exactly to those delineated by Heart 2. Heart 1 showed greater agreement with the clinician-outlined heart with a mean DSC of 0.92 compared to 0.82 for Heart 2. Furthermore, the median difference in mean heart dose was smaller for Heart 1 than Heart 2 (0.0 cGy and 2.4 cGy, respectively) when compared to the clinician-delineated heart. However, it should be noted that, owing to the limitations of out-of-field dose calculations, these statistics should be interpreted as estimates only. 19 
3.B | Planning
Automated treatment plan quality was comparable to the original clinical plans in terms of dose homogeneity. No clinically relevant statistically significant differences were observed (P > 0.01) for the target parameters tested ( Table 2 ). The dose distributions given in (Fig. 2) were representative for the patient cohort.
The planning times achieved for the different MLC types following manual retrospective planning are given in (Table 3) . For
MLCi and Agility, utilizing the automated script reduced planning times by 45% and 36% of the respective manual planning times (P < 0.01). Reductions in maximum planning times were also observed (16.1 min for MLCi). Values are specified as median (range). The two SPICE-generated heart structures were compared to a single, clinician-defined heart for each patient. The aim was to reduce outlining and planning times while maintaining plan quality.
T A B L E 1 Comparison between structures defined by an experienced clinician and those created by SPICE.
Volumes
We have shown that SPICE gives clinically acceptable outlines for the heart and lungs (mean DSCs 0.92 and 0.97, respectively) and that the simple scripting solution allows for breast plans to be produced in shorter times whilst maintaining plan quality (6 min vs. Although the use of the breast script to aid planning does not completely eliminate the need for a final plan quality review by a physicist or dosimetrist, it does however, minimize the probability of planner-induced errors. For larger patients and those with more complex and nonstandard shapes, the script may only be capable of providing a starting point for step-and-shoot in terms of the segment shapes. Nevertheless, the script will give the initial segment shapes quickly and the segment weight optimization will produce the best possible dose distribution to satisfy the specified optimization objectives, giving the planner more time to devise more sophisticated Values quoted are median (range). The level for statistical significance is P < 0.01. The SPICE Heart 1 structure is used for reporting.
modifications to the existing segments in order to produce a clinically acceptable dose distribution. Subtle clinical differences between patients will always be challenging for treatment planning automation techniques. 20 Furthermore, given the small difference in mean heart dose between the SPICE-defined Heart 1 structure and the clinician-delineated heart, the Heart 1 volume was deemed to be suitable for use with all clinical breast radiotherapy patients. This brings breast radiotherapy planning practice into concordance with the majority of other tumor sites. In the context of the planning study, the lack of statistically significant changes in mean dose to the heart for the original and scripted plans is beneficial given that the Darby study showed a linear relationship between mean heart dose and the risk of a major cardiac event. It is inevitable that simple partial automation techniques will be superseded by more sophisticated commercial solutions. The method described by Purdie et al. and implemented in the RayStation treatment planning system is such an example. 13 Nevertheless, as we show with this study, there is a role for noncomplex, noncommercial techniques to provide planning efficiencies until it becomes feasible for commercial approaches to be implemented. On a per plan basis, the benefit of such decreases is relatively modest. However, in the context of the yearly departmental workload for breast planning, this small benefit has the potential to translate into much greater planning efficiency.
| CONCLUSION
The SPICE autosegmentation software offers a robust solution to automatic heart and lung delineation for breast patients and enables plan adjustment based on heart doses without introducing the burden of manual outlining. Partial automation of the breast radiotherapy treatment planning procedure through Pinnacle 3 scripting facilitates reductions in planning times without compromising plan quality.
